H. Lippton et al., PRODEPIN - A NEW PRODUCT OF THE ADRENOMEDULLIN (ADM) GENE HAS SYSTEMIC VASODILATOR ACTIVITY, Life sciences, 54(23), 1994, pp. 409-412
Citations number
6
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
The purpose of the present study was to investigate the effects of pro
ducts of the ADM gene other than ADM on systemic hemodynamics in the a
nesthetized rat, rabbit, piglet, cat and dog. Bolus intravenous (i.v.)
injections of rat proADM(22-41) (3-30 mu g) significantly decreased s
ystemic arterial pressure (SAP) and systemic vascular resistance in th
e anesthetized rat. Unlike ADM, rat proADM(22-41) markedly increased c
ardiac output in the rat. Bolus i.v. injections of human proADM(22-41)
up to 500 mu g had not effect in all species studied and rat proADM(2
2-41) had no effect in species other than the rat. The present data su
ggest that rat proADM(22-41) is a novel product of the ADM gene other
than ADM and possesses marked systemic vasodilator activity. The prese
nt data also suggest that the hemodynamic activity of this peptide is
species specific.